UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Annals of oncology, 2012-06, Vol.23 (6), p.1640-1645

2012

Volltextzugriff (PDF)

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of oncology, 2015-06, Vol.26 (6), p.1175-1179

2015

Volltextzugriff (PDF)

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1262-1268

1996

Volltextzugriff (PDF)

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1169-1176

1994

Volltextzugriff (PDF)

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3766-3770

2001

Volltextzugriff (PDF)

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

Annals of oncology, 1999-04, Vol.10 (4), p.433-440

1999

Volltextzugriff (PDF)

Rituximab in indolent lymphoma : The single-agent pivotal trial

Seminars in oncology, 1999-10, Vol.26 (5), p.79-87

1999

Volltextzugriff (PDF)

Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2461-2470

1999

Volltextzugriff (PDF)

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial

Annals of internal medicine, 1999-07, Vol.131 (2), p.88

1999

Volltextzugriff (PDF)

Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study

British journal of haematology, 2020-12, Vol.191 (5), p.806-815

2020

Volltextzugriff (PDF)

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma

Annals of oncology, 2008-03, Vol.19 (3), p.553-559

2008

Volltextzugriff (PDF)

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Annals of oncology, 2016-07, Vol.27 (7), p.1317-1323

2016

Volltextzugriff (PDF)

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

Annals of oncology, 2016-05, Vol.27 (5), p.895-901

2016

Volltextzugriff (PDF)

Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma

Hematological oncology, 2023-06, Vol.41 (S2), p.167-168

2023

Volltextzugriff (PDF)

Bone mineral density screening should be routine in lymphoma patients

Annals of oncology, 2014-04, Vol.25 (4), p.913-914

2014

Volltextzugriff (PDF)

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1734-1741

1995

Volltextzugriff (PDF)

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Blood, 2001-12, Vol.98 (13), p.3595-3599

2001

Volltextzugriff (PDF)

Clinical Correlates of Elevated Serum Levels of Interleukin-6 in Patients with Untreated Hodgkin's Disease

The American journal of medicine, 1997-01, Vol.102 (1), p.21-28

1997

Volltextzugriff (PDF)

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Journal of clinical oncology, 1992-05, Vol.10 (5), p.790-794

1992

Volltextzugriff (PDF)

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

Annals of oncology, 2002-02, Vol.13 (2), p.318-322

2002

Volltextzugriff (PDF)

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

Annals of oncology, 2001-07, Vol.12 (7), p.923-927

2001

Volltextzugriff (PDF)

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Seminars in oncology, 2000-12, Vol.27 (6), p.37-41

2000

Volltextzugriff (PDF)

Thalidomide for patients with recurrent lymphoma

Cancer, 2004-03, Vol.100 (6), p.1186-1189

2004

Volltextzugriff (PDF)

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Journal of clinical oncology, 1997-12, Vol.15 (12), p.3488-3495

1997

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(258)

Publikationsform

Artikel
(288)
Tagungsberichte
(2)

Sprache

Englisch
(290)

Erscheinungsjahr

n.n

Thema

Humans
(185)
Life Sciences & Biomedicine
(164)
Science & Technology
(164)
Male
(132)
Adult
(126)
Female
(125)
Middle Aged
(123)
Oncology
(120)
Biological And Medical Sciences
(109)
Medical Sciences
(107)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(94)
Aged
(91)
Pharmacology. Drug Treatments
(54)
Chemotherapy
(52)
Combined Modality Therapy
(51)
Neoplasm Staging
(49)
Hematologic And Hematopoietic Diseases
(48)
Hematology
(48)
Antineoplastic Agents
(47)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

Rituximab in indolent lymphoma : The single-agent pivotal trial

Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial

Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma

Bone mineral density screening should be routine in lymphoma patients

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Clinical Correlates of Elevated Serum Levels of Interleukin-6 in Patients with Untreated Hodgkin's Disease

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Thalidomide for patients with recurrent lymphoma

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Suchergebnisse filtern